Buchler, Tomas http://orcid.org/0000-0001-6667-994X
Poprach, Alexandr
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (NU21-03-00539)
Charles University
Article History
Accepted: 13 December 2023
First Online: 3 February 2024
Declarations
:
: Open access publishing supported by the National Technical Library in Prague. This work was supported by the Ministry of Health of the Czech Republic, Grant NU21-03-00539.
: Alexandr Poprach has received research support from Roche, Bristol Myers Squibb, Merck KGaA, MSD, and Novartis; consulting fees from Bristol Myers Squibb, Astellas, Janssen, and Sanofi/Aventis; and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events from Ipsen, Bristol-Myers Squibb, Roche, Novartis, Pfizer, MSD, and Pfizer, all unrelated to the present paper. Tomas Buchler has received research support from AstraZeneca, Roche, Bristol Myers Squibb, Exelixis, Merck KGaA, MSD, and Novartis; consulting fees from Bristol Myers Squibb, Astellas, Janssen, and Sanofi/Aventis; and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events from Ipsen, Bristol-Myers Squibb, AstraZeneca, Roche, Servier, Accord, MSD, and Pfizer, all unrelated to the present paper.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Review design: TB, AP. First draft: TB. Editing: TB, AP.